| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Chiroscience R&D, Inc., Seattle, WA 98021; and
Oak Ridge National Laboratory, Oak Ridge, TN 37830
Mice hemizygous (Xsf/Y) for the X-linked mutation scurfy (sf) develop a severe and rapidly fatal lymphoproliferative disease mediated by CD4+CD8- T lymphocytes. We have undertaken phenotypic and functional studies to more accurately identify the immunologic pathway(s) affected by this important mutation. Flow cytometric analyses of lymphoid cell populations reveal that scurfy syndrome is characterized by changes in several phenotypic parameters, including an increase in Mac-1+ cells and a decrease in B220+ cells, changes that may result from the production of extremely high levels of the cytokine granulocyte-macrophage CSF by scurfy T cells. Scurfy T cells also exhibit strong up-regulation of cell surface Ags indicative of in vivo activation, including CD69, CD25, CD80, and CD86. Both scurfy and normal T cells are responsive to two distinct signals provided by the TCR and by ligation of CD28; scurfy cells, however, are hyperresponsive to TCR ligation and exhibit a decreased requirement for costimulation through CD28 relative to normal controls. This hypersensitivity may result, in part, from increased costimulation through B7-1 and B7-2, whose expression is up-regulated on scurfy T cells. Although the specific defect leading to this hyperactivation has not been identified, we also demonstrate that scurfy T cells are less sensitive than normal controls to inhibitors of tyrosine kinases such as genistein and herbimycin A, and the immunosuppressant cyclosporin A. One interpretation of our data would suggest that the scurfy mutation results in a defect, which interferes with the normal down-regulation of T cell activation.
This article has been cited by other articles:
|
|
 |
|
  Y. Ren, G. A. Strobel, J. C. Graff, M. Jutila, S. G. Park, S. Gosh, D. Teplow, M. Condron, E. Pang, W. M. Hess, et al. Colutellin A, an immunosuppressive peptide from Colletotrichum dematium Microbiology, July 1, 2008; 154(7): 1973 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, A. Kissenpfennig, M. Mingueneau, S. Richelme, P. Perrin, S. Chevrier, C. Genton, B. Lucas, J. P. DiSanto, H. Acha-Orbea, et al. Th2 Lymphoproliferative Disorder of LatY136F Mutant Mice Unfolds Independently of TCR-MHC Engagement and Is Insensitive to the Action of Foxp3+ Regulatory T Cells J. Immunol., February 1, 2008; 180(3): 1565 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Q. Tran, H. Ramsey, and E. M. Shevach Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-{beta} dependent but does not confer a regulatory phenotype Blood, October 15, 2007; 110(8): 2983 - 2990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Allan, S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production Int. Immunol., April 1, 2007; 19(4): 345 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Liston, A. G. Farr, Z. Chen, C. Benoist, D. Mathis, N. R. Manley, and A. Y. Rudensky Lack of Foxp3 function and expression in the thymic epithelium J. Exp. Med., March 19, 2007; 204(3): 475 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Clark and T. S. Kupper IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin Blood, January 1, 2007; 109(1): 194 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Gasper-Smith, I. Marriott, and K. L. Bost Murine {gamma}-Herpesvirus 68 Limits Naturally Occurring CD4+CD25+ T Regulatory Cell Activity following Infection J. Immunol., October 1, 2006; 177(7): 4670 - 4678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Lopes, T. R. Torgerson, L. A. Schubert, S. D. Anover, E. L. Ocheltree, H. D. Ochs, and S. F. Ziegler Analysis of FOXP3 Reveals Multiple Domains Required for Its Function as a Transcriptional Repressor. J. Immunol., September 1, 2006; 177(5): 3133 - 3142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Chen, C. Benoist, and D. Mathis How defects in central tolerance impinge on a deficiency in regulatory T cells PNAS, October 11, 2005; 102(41): 14735 - 14740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bettelli, M. Dastrange, and M. Oukka Foxp3 interacts with nuclear factor of activated T cells and NF-{kappa}B to repress cytokine gene expression and effector functions of T helper cells PNAS, April 5, 2005; 102(14): 5138 - 5143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yagi, T. Nomura, K. Nakamura, S. Yamazaki, T. Kitawaki, S. Hori, M. Maeda, M. Onodera, T. Uchiyama, S. Fujii, et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells Int. Immunol., November 1, 2004; 16(11): 1643 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Eisenbarth and P. A. Gottlieb Autoimmune Polyendocrine Syndromes N. Engl. J. Med., May 13, 2004; 350(20): 2068 - 2079. [Full Text] [PDF]
|
|
|
|
 |
|
 Dermatologic and Immunologic Findings in the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome Arch Dermatol, April 1, 2004; 140(4): 466 - 472.
|
|
|
|
|
|
D. J. Kasprowicz, P. S. Smallwood, A. J. Tyznik, and S. F. Ziegler Scurfin (FoxP3) Controls T-Dependent Immune Responses In Vivo Through Regulation of CD4+ T Cell Effector Function J. Immunol., August 1, 2003; 171(3): 1216 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hori, T. Nomura, and S. Sakaguchi Control of Regulatory T Cell Development by the Transcription Factor Foxp3 Science, February 14, 2003; 299(5609): 1057 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R S Wildin, S Smyk-Pearson, and A H Filipovich Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome J. Med. Genet., August 1, 2002; 39(8): 537 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Khattri, D. Kasprowicz, T. Cox, M. Mortrud, M. W. Appleby, M. E. Brunkow, S. F. Ziegler, and F. Ramsdell The Amount of Scurfin Protein Determines Peripheral T Cell Number and Responsiveness J. Immunol., December 1, 2001; 167(11): 6312 - 6320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Baud, O. Goulet, D. Canioni, F. Le Deist, I. Radford, D. Rieu, S. Dupuis-Girod, N. Cerf-Bensussan, M. Cavazzana-Calvo, N. Brousse, et al. Treatment of the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) by Allogeneic Bone Marrow Transplantation N. Engl. J. Med., June 7, 2001; 344(23): 1758 - 1762. [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Schubert, E. Jeffery, Y. Zhang, F. Ramsdell, and S. F. Ziegler Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation J. Biol. Chem., September 28, 2001; 276(40): 37672 - 37679. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
